Mlp Saglik Hizmetleri As Class B · BIST:MPARK

Mlp Saglik Hizmetleri As Class B — MLP Care — Non-Deal Roadshow (June 2020)

28 slides from Mlp Saglik Hizmetleri As Class B's roadshow presentation, Jun 24, 2020

  1. Slide 1: MLP Care Online Roadshow with Investment Funds in Turkey

    MLP Care Online Roadshow with Investment Funds in Turkey June 24th, 2020

  2. Slide 2: Muharrem Usta, Chairman & CEO

    Muharrem Usta Chairman & CEO 2

  3. Slide 3: Turkey's Healthcare Investments

    Turkey’s Healthcare Investments The number of intensive care beds per Number of beds per 1,000 people over 100,000 people 60 years old 3

  4. Slide 4: At a Glance: MLP Care Operational Highlights

    At a Glance: MLP Care Operational Highlights Two brands and one concept targeting three different price points with consistently outstanding medical service quality The largest hospital group in 30 Hospitals in Total Turkey 20,000+ Staff 1 ~6,000 Beds in Total 2,200+ Doctors (1/3 are academicians) 3

  5. Slide 5: MLP Care & City Hospitals

    MLP Care & City Hospitals İstanbul 9 1 1 Kocaeli 1 2 1 Bursa 3 1 1 Ankara 1 1 1 1 Elazığ İzmir 1 1 2 1 # MLP Care Mersin Gaziantep # PPP’s - opened # PPP’s - planned PPP’s planned to be opened in 2020 PPP’s planned to be opened in 2021  İstanbul Başakşehir City Hospital was opened in May 2020.  An

  6. Slide 6: Our Growth Strategy

    Our Growth Strategy MLP Care continues its asset light growth strategy Expanding in metropolitans through mid-large scale hospitals (min. 100 bed capacity) Quick EBITDA ramp-up through leveraging MLP Care’s resources (brand strength, operational know how, licensing, experienced physicians, and manag

  7. Slide 7: A network of hospitals located strategically across Istanbul

    A network of hospitals located strategically across Istanbul VM Medical Park Maltepe Map of Istanbul Location: Maltepe / Istanbul Opening Date: December 2019 TOTAL CAPEX: 896kTL Key Statistics  20k sqm  135 bed capacity  60 policlinic rooms  7 operating rooms Hospitals with Medical Park Brand Ho

  8. Slide 8: Growth Opportunities in Ankara

    Growth Opportunities in Ankara VM Medical Park Ankara Map of Ankara Medical Park Ankara Location: Keçiören / Ankara Opening Date: March 2020 TOTAL CAPEX: 110kTL Hospitals with Medical Park Brand Liv Hospital Hospitals with Liv Hospital Brand Ankara Key Statistics  19k sqm  94 bed capacity  27 pol

  9. Slide 9: Planned M&A in 2020 – 2021

    Planned M&A in 2020 – 2021 # of Hospitals Liv Hospital Gaziantep Liv Hospital İstanbul Target M&A’s (Planned) (Planned) 4 4 2 26 Medical Park Liv Hospital 2020-2021 Additions 2021-2022 Target M&A's Liv Hospital Location  Gaziantep  İstanbul  Metropolis Opening Date  ~ Q4 2020  ~ Q1 2021  2021-

  10. Slide 10: # of People with Top-up Insurance Close to 1.5 million

    # of People with Top-up Insurance Close to 1.5 million # of People with Top-up Insurance in Turkey 05.2020; 1,452 12.2019; 1,354 CAGR Growth 05.2019; 979 (2014-2018) (May 2019 – May 2020) 12.2018; 920 %84,0 %48,3 LTM Net Addition to Number of People with Top-up Insurance +356k Top-up LTM Top-up Addi

  11. Slide 11: Well Positioned to Rebound After COVID-19

    Well Positioned to Rebound After COVID-19 Medical Tourism Revenue (TLm) 500 435  Diversified and Balanced Geography. 400 330 Patients comes from: 300 188 200 113 28% Europe 33% 100 Middle East and Africa 0 2016 2017 2018 2019 38% Former CIS and the Rest High base in 2019 &  Strong marketing throug

  12. Slide 12: Accelerated Efforts for Digitalisation After Pandemic

    Accelerated Efforts for Digitalisation After Pandemic Robotic Process Automation (RPA) & Artificial Intelligence (AI) & DataLake GDPR (KVKK) Marketing Finance & Accounting Contract Management & Legal Human Resources Procurement & Supply Chain Management Command Center 12

  13. Slide 13: Burcu Öztürk, CFO

    MLPCARE Burcu Oztiirk CFO MEDICALPARK | VWWospitac 13

  14. Slide 14: Operational & Financial Updates: COVID-19 Precautions

    Operational & Financial Updates Precautions Taken Regarding the COVID-19 Pandemic We have taken all precautionary actions to decrease the effect of Covid-19 on our financial performance. Cost Management:  Personnel Expenses: Government’s Incentive of Short-time Work Program was utilized between Apr

  15. Slide 15: At a Glance: MLP Care Q1 2020 Financial Highlights

    At a Glance: MLP Care Q1 2020 Financial Highlights Adj. EBITDA Revenue TL 979 million TL 235 million  All hospitals started accepting COVID-19 5% Growth 2% Growth patients in March  Revenue growth despite the COVID-19 pandemic impact Net Debt /  EBITDA margin eroded slightly supported EBITDA FCF

  16. Slide 16: Revenue Up 5% in Q1 2020

    Operational & Financial Updates Revenue Up 5% in Q1 2020 Revenue (TLm) 6.7% 4.9% 1,107 1,037 979 933 Q1 2019 Q1 2020 Q1 2019 Q1 2020 1 Revenue Including Managed Hospitals: Revenues of Florya, ISU Gaziosmanpaşa and ISU Bahçeşehir were included Denotes growth of Revenue vs. the same period of the last

  17. Slide 17: Revenue Growth in Q1 2020 Despite Pandemic Impact

    Operational & Financial Updates Revenue Growth in Q1 2020 Despite Pandemic Impact Domestic Patient Medical Tourism Ancillary Business Revenues Revenues 11.3% 1.5% (24.0%) 10.2% (5.6%) 926 128 807 72 100 Q1 2020 Q1 2020 Q1 2020 Q1 2020 Q1 2020 Growth Continued in Q1 2020 Slow down in Medical Tourism

  18. Slide 18: Domestic Patient Revenues: Strong improvement in ARPV and ARPP

    Operational & Financial Updates Domestic Patient Revenues: Strong improvement in both ARPV and ARPP in Q1 2020 Outpatient Revenues (TLm) Inpatient Revenues (TLm) 9.2% 10.8% 19.2% 19.1% (10.0%) (8.3%) 500 (30) 450 (36) 82 58 400 350 302 330 430 477 300 250 200 Q1 2019 Volume & Price Q1 2020 Q1 2019 V

  19. Slide 19: EBITDA Up by 2% in Q1 2020

    Operational & Financial Updates EBITDA Up by 2% in Q1 2020 EBITDA (TLm) 1 1.9% (1.3%) 231 235 221 218 2 2 Q1 2019 Q1 2020 Q1 2019 Q1 2020 1 Adj. EBITDA: EBITDA TFRS adjustments that have no cash impact on relevant period and one-off income/expense items 2 Adj. EBITDA: Adj. EBITDA without foreign exc

  20. Slide 20: Smart Cost Management Results in Profitability Growth

    Operational & Financial Updates Smart Cost Management Results in Profitability Growth Cost of Service and G&A Expenses as a % of Revenues  Material costs as a % of revenue declined in Q1 Adj. EBITDA Margin 24.7% 24.0% 2020 due to decrease in the share of laboratory business which has higher cost ba

  21. Slide 21: Debt Position in Q1 2020

    Operational & Financial Updates Debt Position in Q1 2020 FX BASED NET DEBT1 (in EUR m) NET DEBT Q1 20201 EUR30m EUR6m 100 equivalent of equivalent of 90 85 FX Cash Balance FX Cash Balance 80 70 66 60 50 40 85 30 65 20 10 - Net Hard Q1 2020 FMT Currency Debt Revenue (LTM) (in EUR) (in EUR) 2019 Q1 20

  22. Slide 22: Easing CB Policy Rate

    Operational & Financial Updates Easing CB Policy Rate CBT Interest Rate % 24.00 24.00 24.00 24.00 16.50 16.50 12.00 9.75 8.00 8.25 Q1 2018 Q2 2018 Q3 2018 Q4 2018 Q1 2019 Q2 2019 Q3 2019 Q4 2019 Q1 2020 May.20  Central Bank of Turkey policy rates has positive impact on our interest costs since 3Q 2

  23. Slide 23: Total Capex Decreased, Operating Cash Flow Improved

    Operational & Financial Updates Total Capex Decreased, Operating Cash Flow Improved Maintenance Capex (TLm) Total Capex (TLm) Operating Cash Flow / EBITDA 87.4% 2.0% 4.3% 250 25 1.5% 50 3.7% 200 38.2% 20 40 205 20 40 150 15 30 36 10 14 20 100 5 10 50 88 - - - Q1 2019 Q1 2020 Q1 2019 Q1 2020 Q1 2019

  24. Slide 24: MLP Care

    MLPCARE MEDICALPARK | liWnospitat

  25. Slide 25: Thank You !

    Thank You ! MLP Care Investor Relations Deniz Can Yücel +90 212 227 5555 (Ext: 1148) deniz.yucel@mlpcare.com http://investor.mlpcare.com/en/

  26. Slide 26: Historical Balance Sheet

    Historical Balance Sheet Unaudited Audited TLm March 31, 2020 December 31, 2019 Cash and cash equivalents 386 306 Trade receivables 1,067 991 Inventory 118 90 Short term other assets 374 335 Current assets 1,945 1,722 Tangible and intangible fixed assets 1,453 1,327 Right of use assets 291 235 Defer

  27. Slide 27: Historical P&L Statements

    Historical P&L Statements TLm Q1 2020 Q1 2019 Change (%) Revenue 979 933 4.9% Cost of service (-) (750) (706) 6.2% Gross profit 229 227 0.8% General administration expenses (-) (74) (72) 3.4% Other income from operations 82 63 31.5% Other expenses from operations (-) (67) (60) 11.7% Operating profit

  28. Slide 28: Reconciliation from Reported EBITDA to Adjusted EBITDA

    Reconciliation from Reported EBITDA to Adjusted EBITDA TLm Q1 2020 Q1 2019 Net profit / (loss) 61 11 Tax (income) from operations 25 10 Depreciation and amortization of tangible and intangible fixed assets 62 64 Total interest expenses/(income) and fair value differences of derivative instruments 16

MLP Care — Non-Deal Roadshow (June 2020) on 6ix